Home
Search

News

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Press Releases
Browse All
"Build Back Better Act" Drug Pricing Provisions…
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement after the House of Representatives passed the Build Back Better Act: “The legislation that passed the House today…
Learn more
Patients Empowered with New “Clinical Trials: The…
The Biotechnology Innovation Organization (BIO) today announced the launch of Clinical Trials: The Power of Participation (CTPoP), a website that addresses how clinical trials work, how to enroll in a clinical trial, and what to expect as a clinical…
Learn more
White House’s “Build Back Better” Plan Builds New…
Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), made the following statement: "Last week, Democratic leaders announced they had reached a drug pricing “deal.” We wanted to see the details before…
Learn more
Letters, Testimony, & Comments
Browse All
BIO Comments on Draft Guidance: Reporting Amount…
On Wednesday, December 29th, BIO submitted comments to the Food and Drug Administration’s recent draft guidance for industry entitled, Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the Federal Food, Drug, and…
Learn more
BIO Comments on Draft Guidance: Q13 Continuous…
On Monday, December 13th, BIO submitted comments to the Food and Drug Administration’s recent draft guidance for industry entitled, Q13 Continuous Manufacturing of Drug Substances and Drug Products. The draft guidance was prepared under the auspices…
Learn more
BIO Joins Letter to FDA Commissioner on…
New innovations capable of advancing plant breeding, such as gene editing, have immense potential to improve agriculture and food production. Researchers are exploring genetic innovations aimed at increasing agricultural productivity; improving…
Learn more
Amicus Briefs
Browse All
BIO Files Amicus Brief in Petition for a Writ of…
BIO and AUTM have filed an amicus brief in petition for a writ of certiorari the in American Axle & Manufacturing, Inc., v. Neapco Holdings LLC, et al., at the Supreme Court of the United States. BIO and AUTM are concerned that…
Learn more
BIO Files Amicus Brief in Support of Rehearing…
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology. 
Learn more
BIO Files Amicus Brief on Case Addressing the…
BIO files an Amicus Brief on rehearing by the Precedential Opinion Panel of the Patent Trial and Appeal Board.
Learn more
Blog Posts
Browse all Blogs
BTN-MTC_Patient-Pharmacy.png
Brand Name Drug Prices Fell in 2021 -- Again.
January 7, 2022
It’s a new calendar year – yet the tired drug pricing control policies of 2021 continue to float around Capitol Hill. Proponents of price controls justify their actions by claiming drug prices are “skyrocketing” and…
Covid Vaccine
Anti-vaccine legislation is expected to increase in 2022
December 22, 2021
As the world contends with the rapidly spreading Omicron variant of COVID-19, getting more people vaccinated and boosted is all the more essential. Unfortunately, however, many state legislatures have presented a slew…
carbon plants
2021 – A year of breakthroughs for low carbon fuel standards state legislation, with more to come in 2022
December 16, 2021
2021 is shaping up to have been either the sixth or seventh hottest year on record. At the heart of this historically hot year is the amount of greenhouse gases that have been produced over the course of the year. One…